Transforming pharmaceutical manufacturing: The AI revolution europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
In an increasingly interconnected world, the convergence of cutting-edge technologies and emerging security threats pose unique challenges that demand proactive solutions. Chemical, biological,.
Preparing A Framework For Artificial Intelligence And Machine Learning Validation A 3-Step Approach pharmaceuticalonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceuticalonline.com Daily Mail and Mail on Sunday newspapers.
Rhino Health Raises $5 Million to Improve AI Workflows in Healthcare Using Federated Learning
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., Feb. 10, 2021 /PRNewswire/ Rhino Health today announced it has closed a $5 million Seed financing round to improve AI-based healthcare solutions. The Rhino Health Platform connects hospitals and AI developers, providing access to a large, continually updated, distributed dataset from a diverse group of patients. Built on the foundation of Federated Learning, Rhino Health powers AI models that deliver consistent results and improve the standard of care. Ultimately, this improves health outcomes for large populations of patients and creates equitable access to advanced AI-based diagnostics and treatment pathways.
To embed, copy and paste the code into your website or blog: The gathering and transmitting of personal data represents a major cyber threat to medical devices and must be extremely carefully thought through.
Q: The FDA’s stance on a regulatory framework for artificial intelligence and machine learning (AI/ML) software as a medical device is continuously evolving. Could you explain the history?
A: Artificial intelligence (AI) is “adaptive,” meaning that it continuously learns algorithms. For this reason, it is sometimes referred to as Machine Learning (ML). Newly designed medical devices that incorporate AI/ML by definition do not have a final “locked” design capable of a single FDA review. In April 2019, the FDA issued a white paper,